StimOxyGen

To add a bio or update company history, please click update information.

News from StimOxyGen

StimOxyGen raises £1.5m seed led by DSW Ventures to advance oxygen-based cancer therapy

11 Mar 2025

StimOxyGen raises £1.5m seed led by DSW Ventures to advance oxygen-based cancer therapy

StimOxyGen develops oxygen delivery therapies designed to improve tumour response to radiotherapy and immunotherapy by addressing hypoxia in solid cancers, initially focusing on pancreatic cancer.

StimOxyGen

Life Sciences
Coleraine, United Kingdom
£1.5m
stimoxygen.com
Update Information

More venture news

Sequential Bio
17 Mar 2026
Sequential secures £2.6m in funding led by Sparkfood and Corundum Systems Biology for non-invasive testing of skin health ingredients
EquityLife Sciences
Ternary Therapeutics
16 Mar 2026
Ternary Therapeutics raises a £3.6m seed round led by daphni to engineer molecular glue medicines
SeedLife Sciences

StimOxyGen

News from StimOxyGen

StimOxyGen raises £1.5m seed led by DSW Ventures to advance oxygen-based cancer therapy

More venture news

Sequential secures £2.6m in funding led by Sparkfood and Corundum Systems Biology for non-invasive testing of skin health ingredients

Ternary Therapeutics raises a £3.6m seed round led by daphni to engineer molecular glue medicines